AleAnna, Inc. Reports Fiscal Year 2024 Results
A Series of Milestones, Including Public Listing, Were Achieved in 2024; Longanesi First Gas Production Has Been Achieved Fiscal Year […]
Binah Capital Group Reports Fourth Quarter and Full Year 2024 Results
– Grew Total Revenue 8% Year-over-Year to $45 Million in the Fourth Quarter 2024 – – Assets Under Management (“AuM”) […]
Nova LifeStyle Announces Fiscal 2024 Financial Results
LOS ANGELES, March 31, 2025 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced financial […]
Zevra Therapeutics Files Preliminary Proxy
Confirms Receipt of Two Director Nominees from Daniel J. Mangless Stockholders Are Not Required to Take Action at This Time […]
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 2024
TEL-AVIV, Israel, March 31, 2025 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a […]
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome […]
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer Biomea preparing icovamenib for late-stage clinical development Multiple milestones anticipated in 2025 […]
FRP Holdings Announces Investor Day, Conference Participation and its New Investor Website and Presentation
JACKSONVILLE, Fla., March 31, 2025 (GLOBE NEWSWIRE) — FRP Holdings, Inc. (NASDAQ: FRPH) announced today several updates regarding its investor […]
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights
Announced demonstrated ability to deliver transient gene therapy (payload) to tumors using systemic antitumor virotherapy platform Filed IND in March […]
Archimedes Tech SPAC Partners II Co. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 3, 2025
CLAYMONT, Del., March 31, 2025 (GLOBE NEWSWIRE) — Archimedes Tech SPAC Partners II Co. (Nasdaq: ATIIU) (the “Company”) today announced […]
